perampanel: Clinical Trials

31 trials of perampanel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 4 terminated, 2 recruiting, 2 unknown. 31 Phase 2, 4 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 231Completed 21, Terminated 4, Recruiting 2, Unknown 2, Active not recruiting 1, Withdrawn 1
Phase 14Completed 4
Phase 32Completed 2

Follow perampanel: new trials by email Literature Review of perampanel trials Research Report on perampanel

Trials (filtered) newest first · largest first

All 31 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
Perampanel, Placebo - Heart Arrest, Seizures
Phase 2RecruitingUniversity of California, San Francisco522024-05-202026-07-29
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Perampanel 6 MG, Ketamine, Placebo - Depressive Disorder, Major Depressive Disorder
Phase 2RecruitingYale University302023-04-032026-05-06
Effect of Perampanel on Peritumoral Hyperexcitability in HGG
Perampanel, Standard of Care - Glioma, Malignant, Surgery
Phase 1 / Phase 2CompletedDana-Farber Cancer Institute122020-11-052024-08-05
Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use Disorder
Perampanel Tablet, Disulfiram - Alcohol Disorders
Phase 1 / Phase 2CompletedVirginia Commonwealth University42020-10-152022-10-07
Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients
Fycompa - Amyotrophic Lateral Sclerosis
Phase 2TerminatedAmerican University of Beirut Medical Center62019-12-012021-09-01
Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence
Perampanel, Placebo - Alcoholism
Phase 1 / Phase 2CompletedVirginia Commonwealth University222019-06-012023-08-18
A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy
Perampanel Oral Suspension, Perampanel Tablet - Pediatric Epileptic Syndrome, Partial-onset Seizures
Phase 2Active not recruitingEisai Inc.1002019-05-312026-07-10
A Study of Intravenous Perampanel in Japanese Participants With Epilepsy
Perampanel - Epilepsy, Seizures
Phase 2CompletedEisai Co., Ltd.212018-11-272021-01-05
Safety and Tolerability of Perampanel in Cervical Dystonia
Perampanel - Cervical Dystonia
Phase 1 / Phase 2CompletedUniversity Health Network, Toronto252017-09-012020-04-07
Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS)
Perampanel, placebo - ALS
Phase 2CompletedTokyo Medical University662017-04-242021-01-15
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
perampanel - Epilepsy
Phase 2CompletedEisai Inc.262017-02-202024-03-15
Fycompa in Subjects With Small Fiber Neuropathy (SFN)
Fycompa, Placebo - Neuropathy, Small Fiber
Phase 2UnknownPNA Center for Neurological Research302016-01-012016-01-27
An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor
Perampanel, Placebo - Essential Tremor
Phase 2UnknownVA Greater Los Angeles Healthcare System162015-10-012016-09-12
Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs
perampanel - Central Nervous System
Phase 2CompletedEisai Inc.632012-01-012016-07-12
A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents
Perampanel, Placebo - Epilepsy
Phase 2CompletedEisai Inc.1332010-09-012019-05-15
A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)
perampanel - Refractory Partial Seizures
Phase 2CompletedEisai Co., Ltd.212009-06-172018-08-29
An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)
E2007 - Refractory Partial Seizures
Phase 2CompletedEisai Co., Ltd.302009-04-012013-02-07
Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)
E2007 (perampanel), Placebo - Neuralgia
Phase 2CompletedEisai Inc.1462008-01-012013-02-15
Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)
E2007 - Neuralgia
Phase 2 / Phase 3CompletedEisai Inc.2622008-01-012016-01-21
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
perampanel, placebo - Parkinson's Disease
Phase 2TerminatedEisai Inc.12007-10-012018-09-06

Showing 20 of 31. Sign in to see all of them.

Conditions studied

Epilepsy (10)  ·  Seizures (9)  ·  Parkinson Disease (6)  ·  Neuralgia (2)  ·  Alcohol-Related Disorders (1)  ·  Alcoholism (1)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Bipolar Disorder (1)  ·  Depressive Disorder (1)  ·  Depressive Disorder, Major (1)  ·  Diabetic Neuropathies (1)  ·  Essential Tremor (1)  ·  Glioma (1)  ·  Heart Arrest (1)  ·  Neuralgia, Postherpetic (1)

Sponsors

Eisai Inc. (15)  ·  Eisai Co., Ltd. (5)  ·  Virginia Commonwealth University (2)  ·  American University of Beirut Medical Center (1)  ·  Dana-Farber Cancer Institute (1)  ·  Eisai Limited (1)  ·  PNA Center for Neurological Research (1)  ·  Tokyo Medical University (1)  ·  University Health Network, Toronto (1)  ·  University of California, San Francisco (1)  ·  VA Greater Los Angeles Healthcare System (1)  ·  Yale University (1)

Countries

United States (21)  ·  Germany (5)  ·  Czechia (4)  ·  Japan (4)  ·  Latvia (4)  ·  Spain (4)  ·  Belgium (3)  ·  France (3)  ·  Australia (2)  ·  Canada (2)  ·  Italy (2)  ·  Estonia (1)  ·  Finland (1)  ·  Hungary (1)  ·  India (1)

Top investigators

Albert Arias, MD (1)  ·  Albert Arias, MD, PhD (1)  ·  Alessia Nicotra, M.D., Ph.D. (1)  ·  Allison Mann, MD (1)  ·  Antonio Laurenza, M. D. (1)  ·  Antonio Laurenza, M.D. (1)  ·  Charles A Handforth, M.D. (1)  ·  David Squillacote, MD (1)  ·  Edilberto Amorim, MD (1)  ·  Haichen Yang, M.D., M.A. (1)  ·  Hidetaka Hiramatsu (1)  ·  Johnny Salameh, MD (1)  ·  Jonathan Webster (1)  ·  Jong Woo Lee, MD, PhD (1)  ·  Julia Yang, MD, MBA (1)

Results publications

PMID 35305920, PMID 37059702, PMID 21883097, PMID 22913800, PMID 26724782, PMID 29653338, PMID 30739576, PMID 39499201

NIH funding

R21AA026681 (2), 2004 (1), 2005 (1), 2018 (1), P50CA165962 (1)